{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:18:45Z","timestamp":1772439525743,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ITT"],"DOI":"10.2147\/itt.s64795","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T01:11:58Z","timestamp":1466125918000},"page":"57","source":"Crossref","is-referenced-by-count":11,"title":["Prion diseases: immunotargets and therapy"],"prefix":"10.2147","author":[{"given":"Peter","family":"Panegyres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,6]]},"container-title":["ImmunoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=30922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:52:07Z","timestamp":1477867927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/prion-diseases-immunotargets-and-therapy-peer-reviewed-article-ITT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/itt.s64795","relation":{},"ISSN":["2253-1556"],"issn-type":[{"value":"2253-1556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}